OpenAI’s CEO, Sam Altman, has become the latest big tech CEO to pledge support for President-elect Donald J. Trump‘s inauguration. He states he will give a million dollars to an inaugural fund—despite his company’s precarious financial position.
In a statement, Altman expressed his support for Trump’s leadership in advancing artificial intelligence in the United States. The funding pledge, announced Friday, December 13, aligns Altman with other tech executives and companies seeking to foster better relations with Trump.
This development follows announcements earlier this week from tech giants Amazon and Meta, each committing $1 million to the same fund. Amazon has had a fractious relationship with Trump, notably due to his past criticisms of Amazon founder Jeff Bezos and his ownership of The Washington Post.
However, Bezos recently took to social media to express optimism about Trump’s upcoming administration. He had a hand in The Washington Post refusing to endorse Democratic candidate Kamala Harris.
Similarly, Trump previously criticized Meta’s social media platforms for censorship of conservatives. Yet, this relationship may also be changing, with Meta’s CEO, Mark Zuckerberg, meeting with Trump at Mar-a-Lago recently. […]
— Read More: thenationalpulse.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
